Core Viewpoint - The 2025 Microbiome International Probiotic and Health Summit, co-hosted by Weikang Probiotics and the APC Microbiome Centre of Ireland, emphasizes the theme "Quality Bacteria, Quality Life," focusing on the forefront of probiotic research, evidence-based innovation, and sustainable development strategies in the industry [1][8]. Group 1: Keynote Addresses - Dr. Fang Shuguang, Chairman and Chief Scientist of Weikang Probiotics, and Paul Ross, a member of the American Academy of Microbiology and the Royal Irish Academy, delivered keynote addresses at the summit [5][9]. - The summit highlighted the transition of the global probiotic industry towards a science-based, quality-focused, and industrialized era, advocating for rigorous research design and traceable data for quality control [8][11]. Group 2: Research Reports - Renowned scholars, including Catherine Stanton from the Royal Irish Academy and experts from Fudan University and Suzhou University, presented reports on core topics such as cutting-edge probiotic research, scientific evidence, and future development [13]. - Catherine Stanton discussed the establishment of infant gut microbiota and its impact on host health, emphasizing the role of various factors in gut diversity and the clinical benefits of specific probiotics [14][16]. - Other presentations included innovative approaches to gut health management, the necessity of clinical evidence for probiotics, and the potential of probiotics in cancer treatment and chronic disease management [18][20][22][27]. Group 3: Industry Collaboration and Future Directions - The summit served as a vibrant platform for intellectual exchange, fostering meaningful collaborations and innovations in the probiotic field [11]. - Weikang Probiotics is committed to its mission of "Quality Bacteria, Quality Life," focusing on probiotic strain research, clinical evidence, and large-scale production to provide high-quality probiotic solutions for global consumers [27].